Ketamine in Acute Brain Injury Patients.

Clinical trial NCT05097261 · RECRUITING

Trial details

NCT number: NCT05097261
Sponsor: Geert Meyfroidt, MD, PhD
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Brain Injuries, Traumatic

Start date: 2021-09-06
Primary completion: 2025-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.